Uluslararası 6. Psikiyatri kongre Duyurusu

Uluslararası VI. Alzheimer Hastalığı ve İlişkili Bozukluklar Ortadoğu temalı Kongre, İstanbul’da 25-27 Ekimde yapılacaktır. İlginize kongre duyurusunu ve ön kongre programını sunuyoruz. – TürkPsikiyatri|



We are pleased to announce the Sixth International Conference on Alzheimer’s Disease and Related Disorders in the Middle East!  Alzheimer’s disease and related illnesses have received relatively little attention in the region of the Middle East, an area with a population of over 225 million people. The progressive aging of Middle Eastern populations supports the importance of dementia studies in the region.

In April 2001, a meeting endorsed by the World Federation of Neurology, Alzheimer’s Disease International and the Pancyprian Association of Alzheimer’s Disease was held in Cyprus to bring together workers concerned with the medical and social aspects of dementia.  Based upon the success of that first conference, four additional installments of this conference have been convened in the region. Participants have included physicians and scientists from across the Middle East, Europe, United States and other countries around the globe. In each of these conferences plenary lectures were presented by world-renowned experts in Alzheimer’s disease and related disorders.  Other presentations covered all aspects of dementia, mild cognitive impairment and related illnesses, including diagnosis, treatment, pathophysiology, pathology, genetics, epidemiology, and health economics.  Recent results from clinical trials in Alzheimer’s disease were presented, with consideration of the possibilities for extending availability of clinical trials to Middle East populations.

We believe that we need to ensure a continuity of such meetings in the Middle East, in order to demonstrate our common aim to conquer Alzheimer’s disease and related disorders as well as our solidarity as scientists and physicians across borders, ethnicity, religion and gender.  With our Sixth International Conference on Alzheimer’s Disease and Related Disorders in the Middle East, we hope to ensure this continuity and build upon the successes of our previous five editions.  With our two days of sessions, we will be bringing together, once more, a distinguished group of speakers, allowing more opportunities to learn together, network, collaborate and raise awareness of dementia, Alzheimer’s disease and related disorders in the region.

We hope you will consider joining us and look forward to welcoming you to the conference in October.

Changiz Geula, Ph.D.



Marwan Sabbagh, M.D.



Robert Friedland, M.D.



Murat Emre, M.D.

Local Organizer


 Preliminary Program

Clinical Course of Alzheimer’s Disease: The Egyptian Experience

Nasser Loza, MD, Medical Director
Behman Hospital, Cairo, Egypt

Copper, cholesterol and Cognition in Jordan

Eman Al-Khateeb, MBChB, MSc (UCLA), PhD, Professor of Neurophysiology
Faculty of Medicine, University of Jordan, Amman, Jordan

Illiteracy, Cognition and Dementia: A Challenge in Dementia Research in Middle East

Maryam Noroozian, MD, Associate Professor of Neurology
Tehran University of Medical Sciences, Tehran, Iran

Conversion from MCI to AD in an Arabic elderly population in Israel

Rivka Inzelberg, PhD, Professor of Neuroscience
The Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel

Parkinson’s Disease Dementia

Murat Emre, MD, Professor of Neurology, Director Behavioral Neurology and Movement Disorders Unit
Faculty of Medicine, Istanbul University, Istanbul, Turkey

Atrial Fibrillation Predicts Cognitive Impairment in Patients with Ischemic Stroke

Eliyahu H. Mizrahi, M.D., Clinical Lecturer
Sackler Faculty for Medicine, Tel Aviv University, Tel Aviv, Israel

Healthy brain aging and the multiple reserve hypothesis

Robert Friedland, MD, Professor, Department of Neurology
University of Louisville, Louisville, Kentucky, USA

Structural Basis of Amyloid Toxicity: from Biophysics to Therapeutic Strategies

Hilal Lashuel, PhD, Associate Professor of Neuroscience
Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

Association of Methylene Tetra Hydro Folate Reductase 677T Gene Polymorphisms and 
Susceptibility to Alzheimer’s Disease in the Egyptian Population

Doaa Hewedi, PhD, Assistant Professor of Psychiatry and Geriatric Psychiatry Consultant, Ain Shams University, Cairo – Egypt

Common Pathogenic Mechanisms of Down Syndrome and Alzheimer’s Disease

Ahmad Salehi, M.D. Ph.D. Clinical Associate Professor
Department of Psychiatry & Behavioral Sciences Stanford Medical School, Stanford, California, USA

Cognitive Super Aging: Anatomic and Pathologic Correlates

Changiz Geula, PhD, Professor of Neuroscience
Cognitive Neurology and Alzheimer’s Disease Center Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA

TREM2 mutations: A new Risk Factor for Sporadic Alzheimer’s Disease and a New Genetic Cause for 
Familial Frontotemporal Lobar Degeneration

Hakan Gurwit, MD, Professor of Neurology
Behavioral Neurology and Movement Disorders Unit Faculty of Medicine, Istanbul University, Istanbul, Turkey

Alzheimer’s Disease Treatment – Where Have We Been, Where Are We Going?

Diana Paleacu Kertesz, MD, Lecturer
Department of Neurology at Sackler School of Medicine, Tel Aviv University, Israel

Research Advances in Diagnostics and Therapeutics in Alzheimer’s Disease

Marwan Sabbagh, MD, Research Professor of Neurology
University of Arizona College of Medicine, Phoenix, Arizona, USA

An Alzheimer Center in an Emerging Country: Concept and Usefulness

Riadh Gouider, MD, President of Pan Arab Union of Neurological Societies, Head of Department of Neurology
Razi Hospital La Manouba, Tunis, Tunisia

Establishing Alzheimer’s Associations in the Middle East

Diane Mansour, President
Alzheimer’s Association Lebanon, Beirut, Lebanon

Bir Cevap Yazın

E-posta hesabınız yayımlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir